Sectors
IART
Integra LifeSciences Holdings Corporation
17.50
1 x 17.32
1 x 17.57
bid
ask
+
0.43
2.52%
09:41 AM
timesize
| Ytd | 40.90% | |
| 1y | 37.25% |
17.19
day range
17.52
8.70
52 week range
20.49
| Open | 17.19 | Prev Close | 17.07 | Low | 17.19 | High | 17.52 | Mkt Cap | 1.36B |
| Vol | 20.85K | Avg Vol | 977.73K | EPS | 2.36 | P/E | 7.42 | Forward P/E | 6.62 |
| Beta | 1.21 | Short Ratio | 6.22 | Inst. Own | 100.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 17.84 | 200-d Avg | 13.40 | 1yr Est | 19.56 |
| Income Statement | |||
| Total Revenue | 418.76M | ||
| Revenues (USD) | 418.76M | ||
| Cost of Revenue | 199.02M | ||
| Gross Profit | 219.74M | ||
| Operating Expenses | 200.46M | ||
| Research and Development Expense | 24.25M | ||
| Selling, General and Administrative Expense | 172.44M | ||
| Operating Income | 19.29M | ||
| Interest Expense | 22.99M | ||
| Income Tax Expense | 262.00K | ||
| Net Income | 4.48M | ||
| Net Income Common Stock | 4.48M | ||
| Net Income Common Stock (USD) | 4.48M | ||
| Consolidated Income | 4.48M | ||
| Earnings per Basic Share | 0.06 | ||
| Earnings per Basic Share (USD) | 0.06 | ||
| Earnings per Diluted Share | 0.06 | ||
| Earning Before Interest & Taxes (EBIT) | 27.74M | ||
| Earning Before Interest & Taxes (USD) | 27.74M | ||
| Weighted Average Shares | 77.29M | ||
| Weighted Average Shares Diluted | 78.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 214.42M | ||
| Cash and Equivalents (USD) | 214.42M | ||
| Investments | 59.67M | ||
| Investments Current | 59.67M | ||
| Trade and Non-Trade Receivables | 267.19M | ||
| Current Assets | 1.19B | ||
| Property, Plant & Equipment Net | 583.29M | ||
| Total Assets | 3.56B | ||
| Debt Current | 57.51M | ||
| Total Debt | 2.05B | ||
| Current Liabilities | 330.88M | ||
| Debt Non-Current | 1.99B | ||
| Total Liabilities | 2.52B | ||
| Accumulated Retained Earnings (Deficit) | 423.31M | ||
| Accumulated Other Comprehensive Income | -40.20M | ||
| Shareholders Equity | 1.04B | ||
| Shareholders Equity (USD) | 1.04B | ||
| Assets Non-Current | 2.37B | ||
| Total Debt (USD) | 2.05B | ||
| Deferred Revenue | 11.70M | ||
| Goodwill and Intangible Assets | 1.69B | ||
| Inventory | 492.01M | ||
| Liabilities Non-Current | 2.19B | ||
| Trade and Non-Trade Payables | 82.64M | ||
| Tax Assets | 70.44M | ||
| Tax Liabilities | 6.71M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 38.14M | ||
| Net Cash Flow from Financing | -818.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -22.39M | ||
| Capital Expenditure | -12.31M | ||
| Issuance (Repayment) of Debt Securities | 6.24M | ||
| Net Cash Flow from Investing | -43.28M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -30.98M | ||
| Net Cash Flow from Operations | 22.80M | ||
| Effect of Exchange Rate Changes on Cash | -1.09M | ||
| Share Based Compensation | 5.84M | ||